Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment not inhibited with infliximab

被引：0
|
作者：
Van der Heijde, D. [1 ]
Landewe, R. [1 ]
Deodar, A. [2 ]
Baker, D. [3 ]
Han, J. [3 ]
Xu, W. [3 ]
Williamson, P. [3 ]
Houben, H. [4 ]
Baraliakos, X. [5 ]
Braun, J. [5 ]
机构：
[1] Univ Hosp Masstricht, Maastricht, Netherlands
[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[3] Centocor Res & Dev Inc, Malvern, PA USA
[4] Atrium Med Ctr, Heerlen, Netherlands
[5] Rheumazentrum Ruhrgebiet, Herne, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：85 / 86
页数：2
相关论文
共 50 条
  • [21] Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years
    van der Heijde, Desiree
    Salonen, David
    Weissman, Barbara N.
    Landewe, Robert
    Maksymowych, Walter P.
    Kupper, Hartmut
    Ballal, Shaila
    Gibson, Eric
    Wong, Robert
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (04)
  • [22] Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years
    Désirée van der Heijde
    David Salonen
    Barbara N Weissman
    Robert Landewé
    Walter P Maksymowych
    Hartmut Kupper
    Shaila Ballal
    Eric Gibson
    Robert Wong
    Arthritis Research & Therapy, 11
  • [23] Prediction of progression of radiographic damage over 4 years in patients with ankylosing spondylitis
    Van der Heijde, DMFM
    Wanders, A
    Mielants, H
    Dougados, M
    Landewé, RBM
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 98 - 98
  • [24] Less radiographic progression in patients with active ankylosing spondylitis after 2 years of anti-TNF therapy.
    Baraliakos, X
    Listing, J
    Brandt, J
    Rudwaleit, M
    Zeidler, H
    Sieper, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S631 - S632
  • [25] No inhibition of radiographic progression in patients with Spondylitis ankylosans through 2-year treatment with Infliximab
    Braun, J.
    Landewe, R.
    Baraliakos, X.
    Houben, H.
    Williamson, P.
    Baker, D.
    van der Heijde, D.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 6 - +
  • [26] Infliximab for the treatment of ankylosing spondylitis
    Rudwaleit, M
    Sieper, J
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (08) : 1095 - 1109
  • [27] Treatment of ankylosing spondylitis with infliximab
    Boeger, CA
    Wittwer, H
    Schattenkirchner, M
    Kellner, H
    Kellner, W
    ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (12) : 1159 - 1160
  • [28] Infliximab in the treatment of ankylosing spondylitis
    Grainger, Rebecca
    Harrison, Andrew A.
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (02): : 163 - 171
  • [29] Sustained reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab
    Braun, J.
    Landewe, R.
    Hermann, K. G.
    Deodhar, A.
    Baker, D.
    Han, J.
    Xu, W.
    Williamson, P.
    Van der Heijde, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 64 - 64
  • [30] Sustained reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab
    Braun, J.
    Landewe, R.
    Hermann, K. G.
    Deodhar, A.
    Baker, D.
    Han, J.
    Xu, W.
    Williamson, P.
    van der Heijde, D.
    RHEUMATOLOGY, 2008, 47 : II72 - II72
12345